118 related articles for article (PubMed ID: 7053305)
1. Amiloride in primary hyperaldosteronism.
Griffing GT; Cole AG; Aurecchia SA; Sindler BH; Komanicky P; Melby JC
Clin Pharmacol Ther; 1982 Jan; 31(1):56-61. PubMed ID: 7053305
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
Griffing GT; Melby JC
Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
[TBL] [Abstract][Full Text] [Related]
3. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
Griffing GT; Aurecchia SA; Sindler BH; Melby JC
J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
[TBL] [Abstract][Full Text] [Related]
4. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
Clin Exp Pharmacol Physiol Suppl; 1978; 4():55-63. PubMed ID: 354830
[TBL] [Abstract][Full Text] [Related]
5. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1977 Aug; 7(2):151-7. PubMed ID: 890999
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
[No Abstract] [Full Text] [Related]
7. Amiloride in primary hyperaldosteronism with chronic peptic ulceration.
Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI
Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011
[No Abstract] [Full Text] [Related]
8. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-functional evaluation of a new potassium-sparing diuretic: amiloride].
Boschetti E; Dottorini M; Bentivoglio M; Losito A; Grassi V; Muiesan G
Clin Ter; 1977 Mar; 80(6):530-6. PubMed ID: 862353
[No Abstract] [Full Text] [Related]
10. Amiloride in Bartter's syndrome.
Griffing GT; Komanicky P; Aurecchia SA; Sindler BH; Melby JC
Clin Pharmacol Ther; 1982 Jun; 31(6):713-8. PubMed ID: 7075119
[TBL] [Abstract][Full Text] [Related]
11. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.
Izzo JL; Hong M; Hussain T; Osmond PJ
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1183-1190. PubMed ID: 31347775
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
[TBL] [Abstract][Full Text] [Related]
14. Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
Maronde RF; Barr J; Vlachakis ND; Spencer CA; Chan L
Clin Pharmacol Ther; 1984 Oct; 36(4):431-5. PubMed ID: 6478730
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent.
Ram CV; Holland OB; Kaplan NM
J Clin Pharmacol; 1981; 21(11):484-7. PubMed ID: 7334141
[No Abstract] [Full Text] [Related]
16. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
Larochelle P; Logan AG
Can Med Assoc J; 1985 Apr; 132(7):801-5. PubMed ID: 3884122
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
18. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
19. Effects of hydrochlorothiazide combined with amiloride in atenolol-resistant hypertensive patients.
Corea L; Bentivoglio M; Verdecchia P
Int J Clin Pharmacol Res; 1983; 3(5):367-70. PubMed ID: 6678830
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
